13F Holdings
中文EN

RVTY REVVITY, INC.

Laboratory Analytical Instruments · NYSE · SEC CIK 31791 · Fiscal year ends 12/29

Financial factors as of 2026-10-04 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.6%
TTM net income YoY6.6%
TTM EPS YoY12.6%
Revenue 3-yr CAGR1.7%
Net income 3-yr CAGR-30.1%

Margins

Gross margin—
Operating margin12.6%
Net margin8.6%
FCF margin20.1%
EBITDA margin20.9%

Returns

ROE3.5%
ROA2.1%
ROIC (approx.)3.5%
Asset turnover0.25x

Leverage & solvency

Liabilities / assets36.7%
Debt / equity0.36x
Current ratio2.65x
Interest coverage4.04x

Cash quality & payout

Operating cash flow / net income2.59x
Accruals ratio-3.4%
Payout ratio12.4%
Capex / revenue2.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-28FY20242024-12-29FY20232023-12-31FY20222023-01-01FY20212022-01-02
Income statement
Revenue$2.86B$2.76B$2.75B$3.31B$3.83B
Gross profit———$1.99B$2.43B
R&D expense$215.84M$196.84M$216.58M$221.62M$200.34M
SG&A expense$991.89M$994.07M$1.02B$1.03B$975.19M
Operating income$356.63M$346.74M$300.56M$742.70M$1.26B
Interest expense$92.19M$96.28M$98.81M$103.95M—
Pretax income$268.28M$316.13M$182.98M$651.84M$1.20B
Income tax$28.39M$33.05M$3.47M$139.16M$314.15M
Net income$241.20M$270.38M$693.09M$569.18M$943.16M
EBITDA$761.98M$774.59M$732.33M$1.17B$1.57B
EPS (basic)2.072.215.564.518.12
EPS (diluted)2.072.205.554.508.08
Dividends declared per share0.280.280.280.28—
Weighted avg. shares (diluted)116.59M122.82M124.81M126.43M116.67M
Balance sheet
Cash & equivalents$919.86M$1.16B$913.16M$470.75M$619.34M
Short-term investments—$0$689.92M$0—
Receivables$744.67M$632.40M$632.81M$612.78M$707.94M
Inventory$379.50M$367.59M$428.06M$405.46M$425.89M
Current assets$2.24B$2.35B$3.00B$3.29B$2.44B
PP&E, net$479.25M$482.22M$509.65M$482.95M$485.53M
Goodwill$6.61B$6.46B$6.53B$6.48B$6.63B
Intangibles$2.35B$2.64B$3.02B$3.38B$3.82B
Total assets$12.17B$12.39B$13.56B$14.13B$15.00B
Current liabilities$1.33B$653.10M$1.45B$1.54B$1.21B
Short-term debt$588.83M$242,000$721.87M$470.93M$4.24M
Long-term debt$2.63B$3.15B$3.18B$3.92B$4.98B
Total debt$3.22B$3.15B$3.90B$4.39B$4.98B
Total liabilities$4.92B$4.73B$5.69B$6.75B$7.86B
Shareholders' equity$7.25B$7.67B$7.87B$7.38B$7.14B
Net debt$2.30B$1.99B$2.99B$3.92B$4.36B
Shares outstanding112.28M120.65M123.43M126.30M126.24M
Cash flow statement
Operating cash flow$582.93M$628.30M$91.27M$679.81M$1.41B
Capital expenditure$73.52M$86.65M$81.37M$85.63M$86.02M
Free cash flow$509.41M$541.65M$9.90M$594.18M$1.32B
Investing cash flow-$17.35M$776.16M$1.31B-$132.85M-$4.11B
Financing cash flow-$857.52M-$1.13B-$947.12M-$661.80M$2.94B
Depreciation & amortization$405.34M$427.85M$431.77M$427.00M$311.44M
Stock-based compensation$22.85M$37.81M$41.41M$51.52M$29.68M
Dividends paid$32.80M$34.45M$34.97M$35.34M$32.37M
Share buybacks$820.82M$369.58M$388.88M$80.64M$73.07M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.